Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
BENIGN DISEASES OF THE THYROID Rivka Dresner Pollak M.D Endocrinology. Thyroid gland- anatomy Thyroid gland- anatomy sternocleidomastoid thyroid esophagus vertebra strap muscles trachea jugular v. carotid a. Recommended and Typical Values for Dietary Iodine Intake μg I/day 150 200 90-120 Recommended Daily Intake Adults During pregnancy Children Typical Iodine intakes North America Europe (Germany, Belgium) Switzerland Chile 75-300 50-70 130-160 <50-150 Serum thyroid hormone binding Feedback control Thyroid secretion Free T4, T3 Tissue action Hormone metabolism Protein Bound Thyroid hormone P Fecal excretion THYROID HORMONES TRANSPORT AND METABOLISM TRANSPORT TBG = thyroxine binding globulin TTR = transthyretin % binding- mostly to TBG T4 - 99.5 T3- 95 METABOLISM THYROXINE BINDING GLOBULIN DEIODINASE TYPE 1 & 2 Estrogen Androgen Glucocorticoids Acute illness Chronic illness Liver dis. = = N Serum protein binding of thyroid hormones “Pill effect” Total T4 Bound T4 Free T4 TBG T4 synthesis By liver T4 T4 TBG T4 T4 T4 Regulation of Thyroid hormone secretion Hypothalamus (-) TRH (+) Pituitary (+) (-) T4, T3 Thyroid TSH Assessment of bioactive thyroid hormones Check free hormone levels: Free T4 Free T3 Check thyroid hormone “biosensor’: TSH Thyroid function tests FT4 FT3 pmol/L nmol/L 21 3.0 10 1.2 TSH 4 0.15 Hypo Hyper Hypo Hyper 1o Hypo 1o Hyper Laboratory tests in thyroid disease Anti-thyroid antibodies: Anti-thyroid peroxidase (TPO) Thyroid stimulating antibodies: TSI-Thyroid stimulating imunoglobulins TSH receptor Antibody Thyroglobulin 2. Thyroid scanning Radioactive isotopes of I (131I, 123I) Pertechnetate Generates Data on: - Anatomy - Physiology Normal thyroid scan “Hot nodule” “Cold” nodule Multinodular goiter (MNG) Pertechnetate scan CHEST X-RAY Radio Active Iodine Uptake (RAIU) 50 Hyperthroidism 40 30 Normal 20 Hyperthyroidism with Rapid turnover 10 Hypothroidism 0 0 2 6 12 Time (hours) 18 24 Thyroid abnormalities Function Structure Thyroiditis Hyperthyroidism Hypothyroidism Etiology RX Goiter Nodular Benign Malignant Diffuse Function nl Hyperthyroidism-Etiology • Diffuse toxic goiter (Graves’ disease)- most common in young people • Toxic adenoma (Plummers’ diesease) • Toxic mulitinodular goiter (MNG) • Subacute thyroiditis-Hyperthyroid phase • Hyperthyroid phase of Hashimotos’ thyroiditis • (“Hashitoxicosis) • Factitious hyperthyroidism • Rare causes: -TSHoma -Hydatidiform mole/choriocarcinoma - Multiplex pregnancy - Struma ovarii Graves’ disease • Diffuse toxic goiter • Opthalmopathy • Dermopathy •Acropathy (clubbing) Etiology: Autoimmune Anti-TSH receptor antibodies (stimulating, blocking, neutral) Anti-thyroid antibodies expression of HLA-DR3 association with: -diabetes mellitus-type 1 -Addison’s disease - pernicious anemia myasthenia gravis lupus Graves’ disease • Epidemiology : incidence 0.3-1.5/1000 • Female: Male 5:1 • Most Common cause of hyperthyroidism Thyroid and pituitary function in Graves’ disease T4, T3 (+) (-) TSH (+) Thyroid Stimulating Immunoglobulins (TSI) Graves’ diseaseClinical features Signs: Symptoms: Fatigue palpitations Weight loss Heat intolerance Frequent bowel movements Sweating hyperkinesia In the elderly: Tachycardia Muscle wasting pulse pressure Eye signs Diffuse goiter Lymphadenopathy Splenomegaly Hyperreflexia cardiovascular symptoms, myopathy Graves’ Disease- Goiter Graves diseaseOpthalmopathy Extrathyroidal TSHR is present in retro-orbital adipocytes, muscle cells and fibroblasts Grave’s Opthalmopathy • Class 0 — No symptoms or signs • Class I — Only signs, no symptoms (eg, lid retraction, stare, lid lag) • Class II — Soft tissue involvement • Class III — Proptosis • Class IV — Extraocular muscle involvement • Class V — Corneal involvement • Class VI — Sight loss (optic nerve involvement) Graves’ disease dermopathy Graves disease- diagnosis • Clinical hyperthyroidism • Biochemistry: FT4, TT3 , TSH cholesterol • Serology: anti-TSH receptor antibodies anti-thyroid antibodies Graves’ disease- therapy 1. Antithyroid drugs: Thionamides- 3. Definitive therapy: 131I- Propylthiouracil (PTU) Methimazole (MMI) b-blockers Treat for 12 months side effects: hypothyroidism Surgery- subtotal thyroidectomy side effects: anesthesia morbidity hypoparathyroidism recurrent laryngeal nerve damage hypothyroidism 70% ~30% remission Recurrence Or non-remission Follow-up Anti-thyroid thionamide drugs PTU (propylthiouracil) MMI (methimazole) Dosage: TID Once daily Effect: T4, T3 synthesis inhibits T4→T3(high dose) T4, T3 synthesis (slow) Agranulocytosis*: Non-dose dependent Dose dependent (> 40 mg/day) > 40 yrs Pregnancy: placental transfer placental transfer aplasia cutis *occurrence 0.3-0.6% Treatment of Graves' Orbitopathy • Treatment of patients with Graves' orbitopathy has three components: • Reversal of hyperthyroidism, if present • Symptomatic treatment • Treatment with a glucocorticoid, orbital irradiation, orbital decompression surgery to reduce inflammation in the periorbital tissues • Anti thyroid drugs and thyroidectomy are safe; Radioactive iodine may worsen the situation. The effect of high- dose PTU Pulse rate: FT3 FT4 140 50 45 120 40 Normal range 100 35 30 80 25 Upper limit of normal 20 0 1 2 3 4 5 Days PTU dose mg/day: 1200 600 6 10 9 8 7 6 5 4 3 2 1 0 Subacute thyroiditis Etiology: (Post) viral inflammation of thyroid Symptoms & signs: Hyperthyroidism Painful swelling of thyroid Pain irradiation to ear Fever Sometimes “silent” Laboratory: ESR acute phase reactants (CRP) Subacute thyroiditis- therapy A self limited disease Therapy depends on symptoms/signs Non-steroid anti-inflammatory agents (NSAIDS) b-blockers Corticosteroids Outcome - in 6 months 90% euthytroid Hypothyroidism- classification Primary - TSH↑ 1. Hashimoto’s thyroiditis 2. Post 131I therapy for Grave’s disease 3. Post thyroidectomy 4. Excessive I intake (amiodarone-procor) Secondary TSH ↓ or normal: Hypopituitarism due to adenoma, destructive lesion, ablation TSH↓ Tertiary: Hypothalamic dysfunction (rare) Hypothyroidismclinical features Signs: Symptoms: Fatigue Weakness Weight gain Cold intolerance Constipation Cramps Paresthesias (carpal tunnel) Laboratory: Coarse features Bradycardia Myxedema Anemia serum thyroid hormones, cholesterol anemia (iron def., megaloblastic) Hypothyroidism Hypothyroidism- myxedema Hypothyroidismdifferential diagnosis Serum FT4 and TSH FT4, TSH normal/low Secondary hypothyroidism FT4, TSH TRH test Excessive response Primary hypothyroidism Hypothyroidism- therapy • Levothyroxine 0.05-0.3 mg/day • Combined L-T4 and L-T3 may be beneficial with respect to well-being • In elderly patients (at high risk for CVD), “go low, go slow” Hypothyroidism- treatment Before After Thyroid Storm and Myxedema Coma – rare endocrine emergencies THYROID STORM Acute life threatening exacerbation of thyrotoxicosis Clinical setting History of Graves’ disease and discontinuation of medications/ previously undiagnosed hyperthyroidism. Acute onset of hyperpyrexia (over 40 ˚C) Sweating Marked tachycardia, often with atrial fibrillation Nausea, vomiting, diarrhea Agitation, tremulousness, delirium Occasionally “apathetic” – without restlessness and agitation, but with weakness, confusion, and cardio-vascular dysfunction. THYROID STORM DIAGNOSIS: Largely based on the clinical findings and clinical suspicion. Elevated serum FT4, FT3. Low TSH MANAGEMENT 1. Supportive care Fluids, Oxygen, Cooling blanket,cetaminophen 2. Specific measures Propranolol, 40-80 mg every 6 hours. Antithyroid drugs – PTU. Glucocorticoids - Dexamethasone, 2 mg every 6 hours (due to reduction in glucocorticoids half life) Myxedema Coma Extreme hypothyroidism: • Coma • Hypothermia • Hypoventilation • Hypoglycemia • Hyponatremia • Bradycardia Laboratory: FT4 , FT3, TSH Co2 retention Myxedema Coma- therapy Ventilation Treat: Precipitating factors T4 or T3 I.V. Corticosteroids-50-100mg hydrocortisone every 8 hours Subclinical Hypothyroidism Biochemical definition TSH FT4 AND FT3 NORMAL WHEN TO TREAT? WHEN TSH > 10 AND WHAT ABOUT 4.5<TSH<10???? Subclinical hyperthyroidism • TSH below lower limit of normal (<0.3) • Free T3 & Free T4 – normal • Make sure not over treatment of hypothyroidism • Associated with increased risk of atrial fibrillation in subjects > age 60 and accelerated bone loss in postmenopausal women Always repeat the test before initiating therapy! Amiodarone (Procor)-induced thyroid dysfunction • Each Procor tablet (200 mg) has 75 mg Iodine • Procor can cause: hypothyroidism- does not require discontinue the medication (thyroxine can be added) Hyperthyroidism- anti thyroid drugs have limited efficacy; radioactive iodine doesn’t work Thyroiditis- may require steroids »